MEDIWOUND LTD (MDWD) Stock Earnings Estimates
NASDAQ:MDWD • IL0011316309
17.27 USD
+0.14 (+0.82%)
At close: Feb 13, 2026
17.27 USD
0 (0%)
After Hours: 2/13/2026, 8:23:45 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 26.5M 11.53% | 18.686M -29.49% | 20.222M 8.22% | 21.631M 6.97% | 26.733M 23.59% | 33.802M 26.44% | 65.954M 95.12% | 109.19M 65.55% | 180.92M 65.69% | 211.87M 17.11% | 271.85M 28.31% | 379.49M 39.60% | |
| EBITDA YoY % growth | -6.19M 37.98% | -14.198M -129.37% | -17.917M -26.19% | -21.518M -20.10% | -29.301M -36.17% | -36.26M -23.75% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -7.46M 33.51% | -15.501M -107.79% | -19.4M -25.15% | -25.329M -30.56% | -29.448M -16.26% | -28.019M 4.85% | -12.065M 56.94% | 11.683M 196.83% | 51.75M 342.95% | 72.033M 39.19% | 116.45M 61.66% | 187.06M 60.64% | |
| Operating Margin | -28.15% | -82.96% | -95.94% | -117.10% | -110.16% | -82.89% | -18.29% | 10.70% | 28.60% | 34.00% | 42.84% | 49.29% | |
| EPS YoY % growth | -3.77 -9.91% | -0.77 79.58% | -3.07 -298.70% | -2.18 28.90% | -2.47 -13.01% | -2.24 9.36% | -1.93 13.78% | 0.65 133.86% | 2.41 269.53% | 4.56 89.01% | 6.78 48.77% | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.64 -78.97% | -0.62 -788.86% | -0.59 51.90% | -0.58 -142.25% | -0.59 8.18% | -0.51 18.03% | -0.52 12.07% | -0.57 1.75% | -0.58 2.59% |
| Revenue Q2Q % growth | 6.233M 6.73% | 6.274M 58.63% | 6.908M 21.02% | 7.557M 39.20% | 8.45M 35.57% | 8.091M 28.96% | 8.341M 20.74% | 8.763M 15.96% | 9.084M 7.50% |
| EBITDA Q2Q % growth | -7.411M -60.49% | -6.994M -43.71% | -6.807M -37.14% | -7.29M -36.13% | -7.015M 5.35% | -8.313M -18.86% | -8.325M -22.30% | -9.6M -31.69% | -9.612M -37.04% |
| EBIT Q2Q % growth | -7.725M -26.63% | -7.644M -46.29% | -7.419M -29.79% | -7.49M -14.79% | -7.192M 6.90% | -7.195M 5.87% | -7.334M 1.14% | -7.998M -6.78% | -8.128M -13.01% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.24 75.51% | -0.83 | 0.59 | 71.01% |
| Q2 2025 Q2Q % growth | -1.23 -80.88% | -0.58 | -0.65 | -110.94% |
| Q1 2025 Q2Q % growth | -0.07 93.33% | -0.67 | 0.60 | 89.63% |
| Q4 2024 Q2Q % growth | -0.36 -89.47% | -0.62 | 0.26 | 41.90% |
| Q3 2024 Q2Q % growth | -0.98 -308.33% | -0.45 | -0.53 | -116.72% |
| Q2 2024 Q2Q % growth | -0.68 -780.00% | -0.43 | -0.25 | -58.73% |
| Q1 2024 Q2Q % growth | -1.05 -138.64% | -0.41 | -0.64 | -153.13% |
| Q4 2023 Q2Q % growth | -0.19 83.90% | -0.23 | 0.04 | 18.12% |
| Q3 2023 Q2Q % growth | -0.24 73.63% | -0.45 | 0.21 | 46.83% |
| Q2 2023 Q2Q % growth | 0.10 111.90% | -0.41 | 0.51 | 124.31% |
| Q1 2023 Q2Q % growth | -0.44 47.62% | -0.31 | -0.13 | -41.43% |
| Q4 2022 Q2Q % growth | -1.18 -12.38% | -0.60 | -0.58 | -96.08% |
| Q3 2022 Q2Q % growth | -0.91 -8.33% | -0.71 | -0.20 | -27.45% |
| Q2 2022 Q2Q % growth | -0.84 | -0.69 | -0.15 | -21.70% |
| Q1 2022 Q2Q % growth | -0.84 -20.00% | -0.77 | -0.07 | -8.93% |
| Q4 2021 Q2Q % growth | -1.05 -150.00% | -1.07 | 0.02 | 1.96% |
| Q3 2021 Q2Q % growth | -0.84 -71.43% | -0.92 | 0.08 | 8.80% |
| Q2 2021 Q2Q % growth | -0.84 -9.09% | -0.49 | -0.35 | -72.17% |
| Q1 2021 Q2Q % growth | -0.70 -11.11% | -0.80 | 0.10 | 12.21% |
| Q4 2020 Q2Q % growth | -0.42 | -0.81 | 0.39 | 47.85% |
| Q3 2020 Q2Q % growth | -0.49 | -0.69 | 0.20 | 28.81% |
| Q2 2020 Q2Q % growth | -0.77 | -0.86 | 0.09 | 10.87% |
| Q1 2020 Q2Q % growth | -0.63 | -1.02 | 0.39 | 38.19% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 5.429M 24.66% | 6.779M | -1.35M | -19.91% |
| Q2 2025 Q2Q % growth | 5.708M 12.74% | 5.791M | -83K | -1.43% |
| Q1 2025 Q2Q % growth | 3.955M -20.33% | 5.302M | -1.347M | -25.41% |
| Q4 2024 Q2Q % growth | 5.84M 9.40% | 5.863M | -23K | -0.39% |
| Q3 2024 Q2Q % growth | 4.355M -8.81% | 6.126M | -1.771M | -28.91% |
| Q2 2024 Q2Q % growth | 5.063M 6.08% | 5.161M | -98K | -1.90% |
| Q1 2024 Q2Q % growth | 4.964M 30.67% | 4.761M | 203K | 4.26% |
| Q4 2023 Q2Q % growth | 5.338M -54.06% | 5.432M | -94K | -1.73% |
| Q3 2023 Q2Q % growth | 4.776M -17.66% | 4.84M | -64K | -1.32% |
| Q2 2023 Q2Q % growth | 4.773M 2.21% | 4.264M | 509K | 11.94% |
| Q1 2023 Q2Q % growth | 3.799M -13.85% | 5.252M | -1.453M | -27.67% |
| Q4 2022 Q2Q % growth | 11.62M 111.66% | 6.728M | 4.892M | 72.71% |
| Q3 2022 Q2Q % growth | 5.8M -8.95% | 4.695M | 1.105M | 23.54% |
| Q2 2022 Q2Q % growth | 4.67M -22.94% | 5.382M | -712K | -13.23% |
| Q1 2022 Q2Q % growth | 4.41M -24.62% | 4.38M | 30K | 0.68% |
| Q4 2021 Q2Q % growth | 5.49M -17.69% | 5.638M | -148K | -2.63% |
| Q3 2021 Q2Q % growth | 6.37M -3.92% | 5.78M | 590K | 10.21% |
| Q2 2021 Q2Q % growth | 6.06M 50.37% | 5.74M | 320K | 5.57% |
| Q1 2021 Q2Q % growth | 5.85M 31.76% | 5.536M | 314K | 5.67% |
| Q4 2020 Q2Q % growth | 6.67M | 5.705M | 965K | 16.91% |
| Q3 2020 Q2Q % growth | 6.63M | 5.909M | 721K | 12.20% |
| Q2 2020 Q2Q % growth | 4.03M | 5.066M | -1.036M | -20.45% |
| Q1 2020 Q2Q % growth | 4.44M | 4.131M | 309K | 7.48% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -4.7% | 25.54% | -1.42% | 22.23% |
| Revenue | -16.11% | -22.27% | -7.7% | -11.88% |